Connect Biopharma Holdings CNTB
NASDAQ CNTB
$0.77 +0.01 (+1.32%)
At close: Oct 23, 2026 · 4:00 PM EDT

Connect Biopharma Holdings (CNTB) Gains from Sales and Divestitures (2024 - 2025)

Updated

Connect Biopharma Holdings (CNTB) posted Gains from Sales and Divestitures of -$3,000 for Q4 2025, compared with -$2,000 a year earlier.

Analysis

Connect Biopharma Holdings (CNTB) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends

For FY2025, Connect Biopharma Holdings' Gains from Sales and Divestitures came in at -$37,000.

  • In prior years, Connect Biopharma Holdings' Gains from Sales and Divestitures was -$9,000 in FY2024 and -$102,000 in FY2023.
  • Quarterly Gains from Sales and Divestitures has run from a low of -$34,000 in Q1 2025 to a high of -$2,000 in Q4 2024 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Connect Biopharma Holdings 48.49 Mn -128.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,000.00
Mar 31, 2025 -34,000.00
Dec 31, 2024 -2,000.00
Sep 30, 2024 -7,000.00
API Access

Connect Biopharma Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CNTB&period=max&api_key=YOUR_API_KEY